State PA
Clinical Trials in Pennsylvania
Recruiting clinical trials with at least one study location in Pennsylvania. Data updated daily from ClinicalTrials.gov.
Top Conditions in Pennsylvania
NCT04743791 Phase 4
Recruiting
Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Su...
Condition
Asthma
Enrollment
30 pts
Location
United States
Sponsor
Sally E. Wenzel MD
NCT03550391 Phase 3
Recruiting
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radioth...
Condition
Brain Metastases
Enrollment
206 pts
Location
United States, Canada
Sponsor
Canadian Cancer Trials Group
NCT03684018 Phase 4
Recruiting
Two Dose Levels of Privigen in Pediatric CIDP
Condition
Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Enrollment
30 pts
Location
United States
Sponsor
CSL Behring
NCT07011576 Phase 2
Recruiting
A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants W...
Condition
Colon Cancer
Enrollment
60 pts
Location
United States
Sponsor
SCRI Development Innovations,
NCT06286397 Phase 2
Recruiting
Topical Anti-Androgens in Pilonidal Sinus Disease
Condition
Pilonidal Disease
Enrollment
75 pts
Location
United States
Sponsor
University of Pennsylvania
NCT05525923 N/A
Recruiting
Personalized Postoperative Pain Management Following Thoracic Surgery in Adults
Condition
Thoracic Surgery
Enrollment
200 pts
Location
United States
Sponsor
OpalGenix, Inc
NCT06260059 Phase 4
Recruiting
Efficacy Of Sodium Glucose Transporter Inhibitor (SGLT2I) In Adult Patients With...
Condition
Adult Congenital Heart Disease
Enrollment
40 pts
Location
United States
Sponsor
Anita Saraf
NCT06547489 Phase 2
Recruiting
Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disord...
Condition
Major Depressive Disorder
Enrollment
164 pts
Location
United States
Sponsor
Syndeio Biosciences, Inc
NCT06223360 Phase 2
Recruiting
A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Ear...
Condition
Alzheimer Disease
Enrollment
406 pts
Location
United States
Sponsor
Alzheimer's Disease Cooperativ
NCT06122779 Phase 2
Recruiting
Study to Evaluate Safety, Tolerability and Drug Levels of BMS-986435/MYK-224 in ...
Condition
Heart Failure
Enrollment
208 pts
Location
United States, Argentina, Canada
Sponsor
Bristol-Myers Squibb
NCT05239624 Phase 2
Recruiting
Enfortumab Vedotin and Pembrolizumab in People With Bladder Cancer
Condition
Urothelial Carcinoma
Enrollment
23 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT05995535 Phase 2
Recruiting
Pregabalin Plus Lofexidine for the Outpatient Treatment of Opioid Withdrawal
Condition
Opiate Withdrawal Syndrome
Enrollment
150 pts
Location
United States
Sponsor
University of Pennsylvania
NCT02000089 Phase 3
Recruiting
The Cancer of the Pancreas Screening-5 CAPS5)Study
Condition
Pancreas Cancer
Enrollment
9,000 pts
Location
United States
Sponsor
Johns Hopkins University
NCT05759988 N/A
Recruiting
Cervical Ripening as an Outpatient Method Using the Foley (COMFORT)
Condition
Induction of Labor Affected Fetus / Newborn
Enrollment
2,300 pts
Location
United States
Sponsor
University of Pennsylvania
NCT07164443 Phase 3
Recruiting
A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistan...
Condition
Metastatic Castration-resistant Prostate Neoplasms
Enrollment
663 pts
Location
United States, Australia, Belgium
Sponsor
Janssen Research & Development
NCT06440525 Phase 2
Recruiting
A Study of RSLV-132 in Females With Sjögren's Disease
Condition
Primary Sjögren Syndrome
Enrollment
106 pts
Location
United States
Sponsor
Resolve Therapeutics
NCT06510374 Phase 3
Recruiting
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermedi...
Condition
Intermediate Risk Non-Muscle Invasive Bladder Cancer
Enrollment
454 pts
Location
United States, Canada, France
Sponsor
Ferring Pharmaceuticals
NCT04575935 Phase 3
Recruiting
Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of S...
Condition
Advanced Ovarian Carcinoma
Enrollment
580 pts
Location
United States, Canada, Italy
Sponsor
M.D. Anderson Cancer Center
NCT05490888 Phase 1
Recruiting
Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirr...
Condition
Cirrhosis, Liver
Enrollment
74 pts
Location
United States
Sponsor
PharmaIN
NCT03266627 Phase 2
Recruiting
Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection
Condition
Adenovirus
Enrollment
20 pts
Location
United States
Sponsor
New York Medical College
NCT06904261 Phase 3
Recruiting
A Study of Migalastat in Pediatric Subjects (2 to <12 Yrs) With Fabry Disease an...
Condition
Fabry Disease
Enrollment
8 pts
Location
United States, Belgium, Germany
Sponsor
Amicus Therapeutics
NCT05975983 Phase 2
Recruiting
Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulm...
Condition
Idiopathic Pulmonary Fibrosis (IPF)
Enrollment
40 pts
Location
United States
Sponsor
InSilico Medicine Hong Kong Li
NCT06147037 Phase 1
Recruiting
A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Adva...
Condition
Advanced Solid Tumor
Enrollment
70 pts
Location
United States, Canada
Sponsor
AstraZeneca
NCT04846777 N/A
Recruiting
Brief Smartphone Treatment Study
Condition
Generalized Anxiety Disorder
Enrollment
300 pts
Location
United States
Sponsor
Penn State University
NCT06457503 Phase 4
Recruiting
A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Particip...
Condition
Nasopharyngeal Cancer Recurrent
Enrollment
100 pts
Location
United States, Canada
Sponsor
Coherus Oncology, Inc.